Medicure (MCUJF) Other Non-Current Liabilities (2009 - 2022)
Medicure's (MCUJF) quarterly Other Non-Current Liabilities came in at $33736.8 in Q3 2022, down 24.16% year-on-year from $44486.9 in Q3 2021, and up 4.91% quarter-over-quarter from $32158.0 in Q2 2022.
Medicure (MCUJF) Other Non-Current Liabilities (2009 - 2022) Analysis & Trends
Medicure's Other Non-Current Liabilities history runs 13 years deep, the most recent figure standing at $33736.8 for Q3 2022.
- On a quarterly basis, Other Non-Current Liabilities fell 24.16% year-over-year to $33736.8 in Q3 2022; TTM through Sep 2022 was $33736.8, a 24.16% decrease from a year earlier, with the FY2022 full-year figure at $31579.0, changed N/A from the prior year.
- Other Non-Current Liabilities advanced to $33736.8 in Q3 2022 per MCUJF's latest filing, from $32158.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $1.5 million in Q2 2018 and bottomed at $31579.0 in Q1 2022.
- The 5-year median for Other Non-Current Liabilities is $882637.1 (2019), against an average of $713918.2.
- Across the five-year window, Other Non-Current Liabilities surged 1377.79% in 2018 and tumbled 97.35% in 2020, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $909901.4 in 2018, then surged by 62.26% to $1.5 million in 2019, then tumbled by 97.35% to $39119.8 in 2020, then decreased by 18.88% to $31733.4 in 2021, then grew by 6.31% to $33736.8 in 2022.
- Per Business Quant, the three latest MCUJF Other Non-Current Liabilities figures stand at $33736.8 (Q3 2022), $32158.0 (Q2 2022), and $31579.0 (Q1 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 33,736.83 |
| Jun 30, 2022 | 32,157.97 |
| Mar 31, 2022 | 31,579.02 |
| Dec 31, 2021 | 31,733.44 |
| Sep 30, 2021 | 44,486.92 |
| Jun 30, 2021 | 43,116.94 |
| Mar 31, 2021 | 41,085.15 |
| Dec 31, 2020 | 39,119.79 |
| Sep 30, 2020 | 1.46 Mn |
| Jun 30, 2020 | 1.41 Mn |
| Mar 31, 2020 | 1.45 Mn |
| Dec 31, 2019 | 1.48 Mn |
| Sep 30, 2019 | 882,637.10 |
| Jun 30, 2019 | 861,006.38 |
| Mar 31, 2019 | 884,280.64 |
| Dec 31, 2018 | 909,901.37 |
| Sep 30, 2018 | 1.49 Mn |
| Jun 30, 2018 | 1.51 Mn |
| Mar 31, 2018 | 929,876.10 |
| Dec 31, 2017 | 893,411.96 |